News details - novonordisk-us.com
5 days ago · PLAINSBORO, N.J., Jan. 28, 2025 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic ® to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD ...
FDA OKs Ozempic for Kidney Disease in Diabetes Patients
4 days ago · Jan. 29, 2025 -- The FDA has approved Novo Nordisk's diabetes drug Ozempic to help reduce the risk of worsening kidney disease, kidney failure, and heart-related death in adults with type 2 ...
FDA approves Ozempic to reduce risks from chronic kidney disease …
4 days ago · Novo Nordisk is conducting a different study to understand how and why semgalutide seems to reduce the progression of kidney disease, said Stephen Gough, global chief medical officer and senior ...
F.D.A. Approves Ozempic to Treat Kidney Disease
5 days ago · The F.D.A. based its decision to expand the approved uses of Ozempic on research showing that people with Type 2 diabetes and chronic kidney disease who took the drug had a 24 percent lower ...
US FDA Approves Novo Nordisk's Ozempic to Cut Risk of Diabetic Kidney …
4 days ago · (Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with ...
FDA clears use of Ozempic to protect kidney health
4 days ago · Novo Nordisk on Tuesday won an expanded approval for Ozempic, allowing the company to market its top-selling medicine to reduce the risk of kidney complications in adults with type 2 diabetes and chronic kidney disease. Ozempic is the first GLP-1 drug to win Food and Drug Administration approval for use protecting kidney health. The FDA acted ...
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney …
4 days ago · The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney ...
Novo Nordisk's Ozempic slows diabetic kidney disease …
May 24, 2024 · Novo Nordisk's Ozempic slowed the worsening of kidney dysfunction in patients with type 2 diabetes and lowered the risk of kidney failure, heart problems, stroke and death, according to...
Ozempic Approved By FDA For Chronic Kidney Disease - Forbes
4 days ago · The agency cited findings from a late-stage trial by Novo Nordisk, which reported in March 2024 that—in a trial of more than 3,500 people with type 2 diabetes—Ozempic lowered the risk of ...
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease …
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA's ...
- Some results have been removed